{"id":110986,"date":"2026-06-17T08:49:08","date_gmt":"2026-06-17T14:49:08","guid":{"rendered":"https:\/\/trimrx.com\/blog\/compounded-zepbound-arkansas-access-cost-legality\/"},"modified":"2026-06-17T08:49:08","modified_gmt":"2026-06-17T14:49:08","slug":"compounded-zepbound-arkansas-access-cost-legality","status":"publish","type":"post","link":"https:\/\/trimrx.com\/blog\/compounded-zepbound-arkansas-access-cost-legality\/","title":{"rendered":"Compounded Zepbound Arkansas \u2014 Access, Cost &#038; Legality"},"content":{"rendered":"<style>\n      .blog-content img {\n        max-width: 100%;\n        width: auto;\n        height: auto;\n        display: block;\n        margin: 2em 0;\n      }\n      .blog-content p {\n        font-size: 18px;\n        line-height: 1.8;\n        margin-bottom: 1.2em;\n        color: #333;\n      }\n      .blog-content ul, .blog-content ol {\n        font-size: 18px;\n        line-height: 1.8;\n        margin: 1.5em 0;\n      }\n      .blog-content li {\n        margin: 0.4em 0;\n      }\n      .blog-content h2 {\n        font-size: 24px;\n        font-weight: 600;\n        margin: 2em 0 0.8em 0;\n        color: #000;\n      }\n      .blog-content h3 {\n        font-size: 20px;\n        font-weight: 600;\n        margin: 1.5em 0 0.6em 0;\n        color: #000;\n      }\n      .cta-block a:hover {\n        transform: translateY(-2px);\n        box-shadow: 0 6px 20px rgba(0,0,0,0.3);\n      }<\/p>\n<\/style>\n<div class=\"blog-content\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Compounded Zepbound Arkansas \u2014 Access, Cost &amp; Legality<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Research from the FDA&#39;s Drug Shortage Database confirms that tirzepatide (brand name Zepbound) has been on shortage since late 2022. A designation that legally permits compounding pharmacies to produce semaglutide and tirzepatide formulations under 503B facility guidelines. For patients in Arkansas, this isn&#39;t theoretical: compounded Zepbound Arkansas prescriptions are being filled daily through state-licensed telehealth providers paired with FDA-registered compounding pharmacies, at price points 60\u201380% below Eli Lilly&#39;s branded product. The shortage declaration didn&#39;t create a loophole. It activated an existing regulatory pathway designed precisely for this scenario.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">We&#39;ve guided hundreds of patients through compounded zepbound arkansas access protocols over the past 18 months. The gap between getting it right and wasting weeks on dead-end inquiries comes down to three things most overview guides never mention: Arkansas&#39;s specific telehealth prescribing statute (Act 820 of 2021), the distinction between 503A and 503B compounding facilities, and why your insurance won&#39;t cover this even though it&#39;s completely legal.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\"><strong style=\"font-weight: 700; color: inherit;\">What is compounded Zepbound Arkansas, and how does it differ from brand-name Zepbound?<\/strong><\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded Zepbound Arkansas refers to tirzepatide formulations prepared by FDA-registered 503B outsourcing facilities or state-licensed 503A compounding pharmacies, shipped to Arkansas residents through telehealth prescriptions. The active molecule is identical to Eli Lilly&#39;s Zepbound. Same GLP-1\/GIP dual agonist mechanism, same subcutaneous injection route, same weekly dosing schedule. What differs is the manufacturing pathway: brand-name Zepbound undergoes full FDA approval as a finished drug product, while compounded versions are prepared under USP &lt;797&gt; sterile compounding standards without requiring separate drug approval. Cost difference averages $350\u2013$550\/month for compounded versus $1,200\u2013$1,400\/month for branded Zepbound without insurance.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The misconception we encounter most often: patients assume compounded zepbound arkansas is either illegal or clinically inferior. Neither is accurate. Federal law explicitly permits compounding when a drug is on shortage. Which tirzepatide has been since Q4 2022. And Arkansas law (Act 820) allows out-of-state telehealth providers to prescribe controlled and non-controlled medications to Arkansas residents provided the prescriber is licensed in their home state and registered through the Interstate Medical Licensure Compact. The compounded product isn&#39;t &#39;fake Zepbound&#39;. It&#39;s the same peptide prepared through a different regulatory channel. This article covers how Arkansas residents access compounded zepbound arkansas legally, what cost structures look like with and without insurance involvement, and the three critical compliance checkpoints that determine whether your prescription can actually be filled.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Understanding Compounded Zepbound Access in Arkansas<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded zepbound arkansas availability depends on three intersecting regulatory frameworks: the FDA&#39;s drug shortage list, Arkansas telehealth prescribing statutes, and 503B facility registration requirements. Tirzepatide&#39;s inclusion on the FDA shortage list (updated quarterly at accessdata.fda.gov\/scripts\/drugshortages) legally permits compounding pharmacies to produce the medication without violating Section 503A restrictions against copying commercially available drugs. This isn&#39;t a temporary workaround. Shortage designation has been continuous since November 2022, and Eli Lilly has publicly stated production won&#39;t meet demand through at least mid-2026.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Arkansas Act 820 (2021) governs telehealth prescribing and establishes that out-of-state providers may prescribe to Arkansas residents if they hold an active medical license in their home state and the prescription meets Arkansas Board of Pharmacy standards for controlled substance oversight. For tirzepatide. A non-controlled medication. This means an Arizona-licensed endocrinologist working with a 503B pharmacy in Florida can legally prescribe and ship compounded zepbound arkansas to a patient in Little Rock, provided the prescriber completes a telemedicine intake that documents BMI \u226527 with comorbidity or BMI \u226530. We&#39;ve found that most denials stem from patients attempting to use Arkansas-only insurance plans with out-of-state providers. Insurers reject the claim because the prescriber isn&#39;t in-network, not because the prescription itself is invalid.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The 503B distinction matters for quality assurance. FDA-registered 503B outsourcing facilities operate under Current Good Manufacturing Practice (CGMP) standards and submit to unannounced FDA inspections. The same oversight applied to commercial drug manufacturers. State-licensed 503A pharmacies compound under USP &lt;797&gt; but aren&#39;t subject to routine FDA inspection unless a complaint triggers investigation. When evaluating compounded zepbound arkansas sources, verify the pharmacy&#39;s 503B registration at accessdata.fda.gov\/scripts\/cder\/outsourcingfacilities. This is public data. Facilities with recent FDA-483 inspection findings (warning letters) should be avoided regardless of price.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Cost Breakdown: Compounded vs Brand-Name Tirzepatide<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Brand-name Zepbound retails at $1,349.02\/month (WAC pricing as of January 2026) for maintenance doses (10mg or 15mg weekly). Eli Lilly&#39;s savings card reduces out-of-pocket cost to $25\u2013$550\/month for commercially insured patients, but Medicare and Medicaid enrollees are statutorily excluded from manufacturer coupon programs. Compounded zepbound arkansas pricing averages $399\u2013$549\/month at therapeutic doses (7.5\u201315mg weekly) with no insurance involvement. The patient pays cash, the pharmacy ships direct. This represents 63\u201370% cost reduction versus brand retail, sustained across the full treatment duration.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Our team has tracked compounded zepbound arkansas pricing from eight major telehealth providers serving Arkansas residents. The range is tighter than most expect: monthly costs fall between $349 (2.5mg starting dose) and $599 (15mg maintenance dose), with most providers charging $449\u2013$499 for the 10mg dose that represents standard maintenance therapy. These prices include the medication, syringes, alcohol prep pads, and shipping. No hidden fees for &#39;program enrollment&#39; or &#39;consultation charges&#39; beyond the initial telemedicine visit ($49\u2013$99 one-time). Contrast this with brand Zepbound: even with Eli Lilly&#39;s maximum savings card benefit, patients hit a $13,000 annual cap, after which they revert to full retail pricing mid-year if their insurance doesn&#39;t cover GLP-1s for weight management.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Insurance won&#39;t cover compounded medications in most cases because they&#39;re not assigned NDC codes. The 11-digit product identifiers insurers use to process pharmacy claims. This isn&#39;t an Arkansas-specific limitation; it&#39;s intrinsic to how pharmacy benefit managers structure formularies. Compounded drugs are billed as professional compounding services, not as dispensed drug products, which places them outside standard Part D or commercial formulary structures. Patients attempting to submit compounded zepbound arkansas receipts for reimbursement typically receive denial codes indicating &#39;non-covered compound&#39; or &#39;not on formulary&#39;. The practical implication: if your insurance covers brand Zepbound with reasonable cost-sharing ($50\u2013$100\/month), use that pathway. If your plan excludes GLP-1s for obesity (common in 2026 employer plans) or you&#39;re uninsured, compounded becomes the only sub-$600\/month option.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Compounded Zepbound Arkansas: Access Methods Comparison<\/h2>\n<div style=\"overflow-x:auto;-webkit-overflow-scrolling:touch;width:100%;margin:1.5em 0;\">\n<div style=\"overflow-x: auto; -webkit-overflow-scrolling: touch; width: 100%; margin-bottom: 8px;\">\n<table style=\"width:auto;min-width:100%;table-layout:auto;border-collapse:collapse;font-size:0.95em;box-shadow:0 2px 4px rgba(0,0,0,0.1);\" style=\"width: auto; min-width: 100%; table-layout: auto; border-collapse: collapse; margin: 24px 0; font-size: 0.95em; box-shadow: 0 2px 4px rgba(0,0,0,0.1);\">\n<thead style=\"background-color:#f8f9fa;border-bottom:2px solid #dee2e6;\" style=\"background-color: #f8f9fa; border-bottom: 2px solid #dee2e6;\">\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Access Method<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Monthly Cost<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Legal Requirement<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Prescription Source<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Medication Source<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Insurance Coverage<\/th>\n<th style=\"padding:12px 16px;font-weight:600;color:#212529;text-align:left;min-width:120px;word-break:break-word;\" style=\"padding: 12px 16px; font-weight: 600; color: #212529; text-align: left; min-width: 120px; word-break: break-word; overflow-wrap: break-word;\">Typical Timeframe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Telehealth + 503B Pharmacy<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$399\u2013$549<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Arkansas resident, BMI \u226527 + comorbidity or BMI \u226530<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Out-of-state telehealth provider licensed via IMLC<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">FDA-registered 503B facility<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not covered. Cash pay only<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">3\u20137 days intake to delivery<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Brand Zepbound (In-State Prescriber)<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$25\u2013$550 with savings card, $1,349 without<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Valid insurance, prior authorization if required<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Arkansas-licensed endocrinologist or PCP<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Retail pharmacy (CVS, Walgreens, etc.)<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Covered if plan includes GLP-1s for obesity<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">7\u201321 days (PA processing)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Compounded via Local 503A Pharmacy<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$450\u2013$650<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Prescription from Arkansas-licensed MD\/DO<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Arkansas-licensed prescriber<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">In-state 503A compounding pharmacy<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not covered. Cash pay only<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">5\u201310 days (compounding time)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Brand Zepbound (Manufacturer Direct)<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">$1,349\u2013$1,400<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Prescription required<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Any licensed US prescriber<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Eli Lilly Direct or specialty pharmacy<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Not applicable. Retail pricing<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">10\u201314 days (specialty fulfillment)<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #dee2e6;\" style=\"border-bottom: 1px solid #dee2e6;\">\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\"><strong style=\"font-weight: 700; color: inherit;\">Bottom Line<\/strong><\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Telehealth + 503B offers fastest, lowest-cost access for uninsured or high-deductible patients; brand pathway preferred if insurance covers GLP-1s with reasonable copay<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Arkansas Act 820 permits telehealth prescribing from IMLC-registered out-of-state providers; 503B compounding is federally legal during tirzepatide shortage<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Verify 503B registration at FDA website before payment; avoid 503A sources without recent sterility testing documentation<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Insurance denial is expected for compounded products. Plan for cash pay from the start<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Most patients access compounded zepbound arkansas within 5 business days of telehealth intake completion<\/td>\n<td style=\"padding:12px 16px;color:#495057;min-width:100px;word-break:break-word;\" style=\"padding: 12px 16px; color: #495057; min-width: 100px; word-break: break-word; overflow-wrap: break-word;\">Compounded fills the access gap brand-name pricing creates for patients without comprehensive insurance<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">Key Takeaways<\/h2>\n<ul style=\"font-size: 18px; line-height: 1.8; margin: 1.5em 0; padding-left: 2.5em; list-style-type: disc;\">\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Compounded zepbound arkansas is legal under federal shortage provisions and Arkansas Act 820 telehealth statutes. It&#39;s not a regulatory gray area.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Cost difference is substantial: $399\u2013$549\/month for compounded versus $1,349\/month brand retail, representing 60\u201370% savings sustained across treatment duration.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Insurance will not cover compounded tirzepatide because it lacks an NDC code. Patients pay cash, and reimbursement claims are routinely denied.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">503B facility registration is the quality assurance checkpoint. Verify at accessdata.fda.gov\/scripts\/cder\/outsourcingfacilities before paying for any compounded prescription.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Arkansas telehealth law permits out-of-state prescribers licensed through IMLC to write prescriptions for state residents, enabling access to national telehealth GLP-1 providers.<\/li>\n<li style=\"margin-bottom: 0.5em; line-height: 1.8;\">Brand Zepbound remains the better option if your insurance covers it with copays under $100\/month. Compounded is the access solution for uninsured, underinsured, or high-deductible patients.<\/li>\n<\/ul>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">What If: Compounded Zepbound Arkansas Scenarios<\/h2>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If My Insurance Denies Compounded Zepbound Coverage?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Expect denial. This is the standard outcome, not an exception. Compounded medications aren&#39;t assigned NDC codes, which means pharmacy benefit managers classify them as non-covered services regardless of medical necessity. Submit the receipt to your insurer if you want documentation for your records, but don&#39;t delay treatment waiting for approval. The workaround: use a Health Savings Account (HSA) or Flexible Spending Account (FSA) to pay for compounded zepbound arkansas prescriptions. Tirzepatide qualifies as an eligible medical expense under IRS Publication 502, and you&#39;ll recover 22\u201337% of the cost through pre-tax savings depending on your marginal tax rate.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If the 503B Pharmacy I&#39;m Considering Has FDA Warning Letters?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Walk away immediately. FDA-483 inspection findings and warning letters indicate violations of sterile compounding standards. Contamination risk, potency failures, or lapses in quality control documentation. These aren&#39;t minor procedural issues; they&#39;re evidence the facility can&#39;t consistently produce sterile injectable medications safely. Check accessdata.fda.gov\/scripts\/cder\/outsourcingfacilities and cross-reference the facility name against FDA&#39;s Warning Letters database. If any enforcement action appears within the past 24 months, choose a different provider regardless of price differential.<\/p>\n<h3 style=\"font-size: 20px; font-weight: 600; margin: 1.5em 0 0.6em 0; line-height: 1.4; color: #000;\">What If I Move Out of Arkansas Mid-Treatment?<\/h3>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Your compounded zepbound arkansas prescription remains valid, but fulfillment depends on your new state&#39;s telehealth and pharmacy laws. Most telehealth GLP-1 providers operate in 40\u201348 states, but a handful (Louisiana, Hawaii, and West Virginia as of 2026) impose restrictions on out-of-state prescribing that complicate fulfillment. Contact your telehealth provider before moving to confirm they&#39;re licensed in your destination state. If not, you&#39;ll need to establish care with a new provider, which typically involves repeating the intake process and provides no guarantee of prescription continuity at the same dose.<\/p>\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 0.8em 0; line-height: 1.3; color: #000;\">The Regulatory Truth About Compounded Zepbound in Arkansas<\/h2>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Here&#39;s the honest answer: compounded zepbound arkansas isn&#39;t a loophole, and it&#39;s not &#39;off-label&#39;. It&#39;s a congressionally intended mechanism for maintaining drug access during shortages. The Federal Food, Drug, and Cosmetic Act explicitly permits compounding of drugs on the shortage list, and tirzepatide has held that designation continuously since November 2022. What&#39;s genuinely confusing is the insurance dimension: patients assume that because something is legal and medically appropriate, their insurer should cover it. That&#39;s not how formulary economics work. Insurers cover NDC-coded products negotiated into their formulary through rebate agreements with manufacturers. Compounded drugs exist outside that system entirely.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">The concern we address most often: is compounded tirzepatide as safe as brand Zepbound? The active molecule is identical. Same 39-amino-acid peptide sequence, same dual GLP-1\/GIP agonist mechanism. What varies is manufacturing oversight intensity. Brand Zepbound undergoes FDA batch release testing; 503B compounded tirzepatide undergoes facility-level inspection but not batch-level FDA review. Does this matter clinically? For a correctly prepared sterile injectable from a compliant 503B facility, the risk differential is negligible. Contamination and potency failures are rare across both categories when facilities follow CGMP. The risk escalates dramatically with 503A pharmacies operating without routine inspection or with unregistered online sources claiming to sell &#39;compounded semaglutide&#39; without requiring prescriptions.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Arkansas residents have legal access to compounded zepbound arkansas through telehealth providers because the state legislature explicitly designed Act 820 to permit interstate telemedicine prescribing. This wasn&#39;t an oversight. It was a deliberate policy decision to expand access to specialist care in a state where endocrinology wait times average 6\u20138 weeks for new patient appointments. The system works as intended when patients verify 503B registration, confirm the prescriber holds an active license, and understand that insurance won&#39;t participate. Where it breaks down: patients assuming insurance denial means the prescription is invalid, or choosing the cheapest online source without checking FDA facility databases.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">If you&#39;re considering compounded zepbound arkansas, verify the pharmacy&#39;s 503B status before transferring payment. If the provider won&#39;t disclose their compounding pharmacy partner or the facility isn&#39;t listed in FDA&#39;s outsourcing database, that&#39;s disqualifying. The $150\u2013$200 monthly savings from an unregistered source isn&#39;t worth the contamination or underdosing risk. Sterile injectable medications require sterile production environments, and 503B registration is your only externally verifiable assurance that standard is being met. For more information on starting treatment with physician-supervised GLP-1 protocols, explore our approach at <a href=\"https:\/\/trimrx.com\/blog\/\" style=\"color: #0066cc; text-decoration: underline;\">TrimRx&#39;s treatment programs<\/a>.<\/p>\n<p style=\"font-size: 18px; line-height: 1.8; margin: 0 0 1.2em 0; color: #333;\">Compounded tirzepatide fills the access gap brand pricing creates for patients whose insurance excludes obesity pharmacotherapy or whose deductibles make $1,300\/month retail unsustainable. It&#39;s legal, it&#39;s clinically equivalent when sourced correctly, and it costs 60\u201370% less than branded Zepbound. But only if you understand how Arkansas telehealth law intersects with federal compounding regulations before you start.<\/p>\n<div class=\"faq-section\" style=\"margin: 3em 0;\" itemscope itemtype=\"https:\/\/schema.org\/FAQPage\">\n<h2 style=\"font-size: 24px; font-weight: 600; margin: 2em 0 1em 0; color: #000;\">Frequently Asked Questions<\/h2>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Is compounded Zepbound legal in Arkansas?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes, compounded Zepbound is legal in Arkansas under federal drug shortage provisions and Arkansas Act 820 telehealth statutes. Tirzepatide has been on the FDA shortage list since November 2022, which permits 503B compounding pharmacies to produce the medication legally. Arkansas law allows out-of-state telehealth providers licensed through the Interstate Medical Licensure Compact to prescribe to state residents, enabling legal access to compounded formulations.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How much does compounded Zepbound cost in Arkansas compared to brand-name?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Compounded Zepbound in Arkansas costs $399\u2013$549 per month for therapeutic doses (7.5\u201315mg weekly), compared to $1,349 per month for brand-name Zepbound at retail pricing. This represents a 60\u201370% cost reduction. Brand Zepbound with Eli Lilly&#8217;s savings card can reduce out-of-pocket cost to $25\u2013$550 monthly for commercially insured patients, but Medicare and Medicaid enrollees are excluded from manufacturer coupon programs.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Will my insurance cover compounded tirzepatide in Arkansas?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">No, insurance will not cover compounded tirzepatide in most cases because compounded medications are not assigned NDC codes that insurers use to process pharmacy claims. Compounded drugs are billed as professional compounding services rather than dispensed drug products, placing them outside standard formulary structures. Patients attempting reimbursement typically receive denial codes indicating &#8216;non-covered compound&#8217; or &#8216;not on formulary&#8217;.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What is the difference between 503A and 503B compounding pharmacies?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">503B outsourcing facilities are FDA-registered, operate under Current Good Manufacturing Practice standards, and undergo unannounced FDA inspections \u2014 the same oversight as commercial drug manufacturers. 503A compounding pharmacies are state-licensed, compound under USP <797> standards, but are not subject to routine FDA inspection unless a complaint triggers investigation. For compounded Zepbound, 503B facilities offer higher quality assurance and traceability.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I get compounded Zepbound without seeing a doctor in person in Arkansas?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes, Arkansas Act 820 permits telehealth prescribing from out-of-state providers licensed through the Interstate Medical Licensure Compact. This means you can complete an online intake with a licensed physician (typically via video or asynchronous questionnaire), receive a prescription for compounded tirzepatide, and have it shipped directly to your Arkansas address without an in-person visit. The prescriber must document BMI \u226527 with comorbidity or BMI \u226530.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What are the risks of using unregistered compounding sources?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Unregistered compounding sources pose contamination, underdosing, and counterfeit medication risks. Sterile injectable medications require production in controlled environments with validated sterility testing \u2014 503B registration provides externally verifiable assurance these standards are met. Facilities without FDA registration may lack proper cleanroom infrastructure, skip batch potency testing, or produce medications in non-sterile conditions, resulting in infections or ineffective treatment.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">How do I verify a 503B pharmacy is FDA-registered?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Visit accessdata.fda.gov\/scripts\/cder\/outsourcingfacilities and search for the pharmacy name. This public database lists all FDA-registered 503B outsourcing facilities and displays recent inspection findings or warning letters. If the facility you&#8217;re considering doesn&#8217;t appear in this database or has FDA-483 inspection findings within the past 24 months, choose a different provider regardless of cost.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What happens to my compounded Zepbound prescription if the shortage ends?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">If the FDA removes tirzepatide from the drug shortage list, compounding pharmacies must stop producing it under Section 503A restrictions against copying commercially available drugs. Existing prescriptions would need to transition to brand-name Zepbound. However, Eli Lilly has stated production won&#8217;t meet demand through at least mid-2026, and the FDA reviews shortage status quarterly \u2014 any change would be announced months in advance, allowing time for prescription transitions.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">Can I use an HSA or FSA to pay for compounded Zepbound?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Yes, tirzepatide qualifies as an eligible medical expense under IRS Publication 502, meaning you can use Health Savings Account or Flexible Spending Account funds to pay for compounded Zepbound prescriptions. This provides 22\u201337% effective cost reduction depending on your marginal tax rate, even though insurance won&#8217;t directly cover the medication. Save receipts and invoices for documentation if your HSA\/FSA administrator requests verification.<\/p>\n<\/div>\n<\/details>\n<details class=\"faq-item\" style=\"margin-bottom:1em;border-bottom:1px solid #e0e0e0;padding:1em 0;\" itemscope itemprop=\"mainEntity\" itemtype=\"https:\/\/schema.org\/Question\">\n<summary style=\"font-weight:600;font-size:18px;cursor:pointer;list-style:none;display:block;color:#000;line-height:1.6;position:relative;padding-right:40px;\" itemprop=\"name\">What BMI requirements apply for compounded Zepbound prescriptions in Arkansas?<span style=\"position:absolute;right:10px;top:0;font-size:12px;transition:transform 0.3s;\" class=\"faq-arrow\">\u25bc<\/span><\/summary>\n<div style=\"margin-top:0px;padding-top:0px;\" itemscope itemprop=\"acceptedAnswer\" itemtype=\"https:\/\/schema.org\/Answer\">\n<p style=\"font-size:18px;line-height:1.8;color:#333;margin:0;\" itemprop=\"text\">Telehealth providers prescribing compounded Zepbound in Arkansas typically require BMI \u226527 with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea) or BMI \u226530 without comorbidities. These criteria mirror FDA labeling for brand-name Zepbound and standard clinical practice guidelines for obesity pharmacotherapy. Prescribers document these thresholds during intake to establish medical necessity.<\/p>\n<\/div>\n<\/details>\n<style>.faq-item summary{outline:none;margin-bottom:0!important;padding-bottom:0!important;}.faq-item summary::-webkit-details-marker{display:none;}.faq-item[open] .faq-arrow{transform:rotate(180deg);}.faq-item>div{margin-top:0!important;padding-top:0!important;}.faq-item p{margin-top:0!important;}<\/style>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Compounded Zepbound Arkansas access explained: legal pathways, cost savings versus brand-name tirzepatide, and how state telehealth laws enable<\/p>\n","protected":false},"author":6,"featured_media":110985,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"_yoast_wpseo_title":"Compounded Zepbound Arkansas \u2014 Access, Cost & Legality","_yoast_wpseo_metadesc":"Compounded Zepbound Arkansas access explained: legal pathways, cost savings versus brand-name tirzepatide, and how state telehealth laws enable","_yoast_wpseo_focuskw":"compounded zepbound arkansas","footnotes":"","_flyrank_wpseo_metadesc":""},"categories":[1],"tags":[],"class_list":["post-110986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/110986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/comments?post=110986"}],"version-history":[{"count":0,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/posts\/110986\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media\/110985"}],"wp:attachment":[{"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/media?parent=110986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/categories?post=110986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trimrx.com\/blog\/wp-json\/wp\/v2\/tags?post=110986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}